JPS6395041A - Medical pledget - Google Patents
Medical pledgetInfo
- Publication number
- JPS6395041A JPS6395041A JP61240922A JP24092286A JPS6395041A JP S6395041 A JPS6395041 A JP S6395041A JP 61240922 A JP61240922 A JP 61240922A JP 24092286 A JP24092286 A JP 24092286A JP S6395041 A JPS6395041 A JP S6395041A
- Authority
- JP
- Japan
- Prior art keywords
- pledget
- medical
- tissue
- anastomosis
- trachea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000954 Polyglycolide Polymers 0.000 claims description 7
- 239000004633 polyglycolic acid Substances 0.000 claims description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001169 thermoplastic Polymers 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 2
- 239000000463 material Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 230000003872 anastomosis Effects 0.000 description 8
- 239000004745 nonwoven fabric Substances 0.000 description 8
- 210000003437 trachea Anatomy 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 6
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010003497 Asphyxia Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- HSQFVBWFPBKHEB-UHFFFAOYSA-N 2,3,4-trichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1Cl HSQFVBWFPBKHEB-UHFFFAOYSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- 206010051268 Anastomotic stenosis Diseases 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、縫合、吻合等の外科手術の際に体組織の断裂
を防止する目的をもって適用されるプレジェットの提供
に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to the provision of a pledget that is applied for the purpose of preventing tearing of body tissue during surgical operations such as suturing and anastomosis.
(従来技術)
近年、例えば気管、気管支外科の進歩により呼吸気系の
手術が積極的に行われるようになってきたが、広範な気
管切除の際には特に吻合部にかかる張力が強く、力が集
中するため縫合糸により当該部組織が断裂したり、それ
に伴なう縫合不全、肉芽形成、気管瘤なと重篤な合併症
を誘発させる原因となっている。(Prior art) In recent years, for example, due to advances in tracheal and bronchial surgery, surgeries related to the respiratory system have become more active. However, when performing extensive tracheal resections, the tension applied to the anastomosis is especially strong, and This concentration causes the tissue in question to be torn by the suture, causing serious complications such as suturing failure, granulation formation, and tracheal aneurysm.
また、他の外科的手術においても組織的に軟弱であった
り、或は張力をかけて縫合されるような場合には前記と
同じような問題を生じた。Further, in other surgical operations, problems similar to those described above have occurred when the tissue is weak or sutured under tension.
従来、かかる問題を解消する手段として人体に無害な素
材、例えば、テフロンから成るプレジェットが当て布と
して用いられ、これを当該部に当てた上から縫合、吻合
等を行っていた。Conventionally, as a means to solve this problem, a pledget made of a material harmless to the human body, such as Teflon, has been used as a patch, and sutures, anastomoses, etc. have been performed from above the pledget cloth applied to the relevant part.
しかしながら、かかる従来品によると、気管などのデリ
ケートな部位の縫合においてはしばしば肉芽形成の原因
となり、とりわけ膜様部に使用すると炎症により高率に
内腔へこれが脱落し、周囲に肉芽を発生させる゛原因と
なるため窒息死亡を誘発することが知られている。However, such conventional products often cause granulation formation when suturing delicate areas such as the trachea, and especially when used on membranous areas, they often fall out into the lumen due to inflammation, causing granulation to occur in the surrounding area. It is known to cause death by suffocation.
また、かかる素材は体内吸収性でないため機能が不必要
となってもいつまでも体内に残り、少なからず組織反応
を起しつづけることになる。Furthermore, since such materials are not absorbable in the body, they remain in the body indefinitely even if their function is no longer needed, and they continue to cause considerable tissue reactions.
(発明が解決しようとする問題点)
本発明は、かか、る点、生体内分解性を有する高分子化
合物より成るプレジェットを提供するもので1機能を果
した後体内に残り続けることがなく、また、生体親和性
に優れるため、デリケートな部位への適用も可能である
。(Problems to be Solved by the Invention) In view of the above, the present invention provides a pledget made of a biodegradable polymer compound, which does not remain in the body after performing one function. Moreover, since it has excellent biocompatibility, it can be applied to delicate areas.
(問題を解決するための手段)
しかるに、その特徴とするところは、生体内分解吸収性
の熱可塑性高分子であるポリグリコール酸、或はこれと
乳酸との共重合体より成る合成高分子材料より成り、こ
れのチップを溶融紡糸してマルチフィラメント糸をつく
り、これより得たランダムウェブから不織布を、或は編
、織成した生地を複数枚重ね、これをニードルパンチン
グして不織布化したものを最終的に熱プレスして毛羽や
ほつれをなくし、最後に適当な大きさに小判状にカット
して成るプレジェットであり、その形状を例示すると、
第1図に示すごとく楕円形にカットされた切断片の中央
寄りに2つの針穴(2)(3)をあけてプレジェット(
1)を構成し、これの使用に際しては、第2図に示すご
とく手術時に前記針穴(2)(3)に縫合糸(4)を通
して用いるものである。(Means for Solving the Problem) However, its characteristic feature is that it is a synthetic polymer material made of polyglycolic acid, which is a biodegradable and absorbable thermoplastic polymer, or a copolymer of this and lactic acid. The chips are melt-spun to make multifilament yarn, and the random web obtained from this is made into a nonwoven fabric, or multiple layers of knitted or woven fabric are layered and then needle punched to make a nonwoven fabric. It is a pledget that is finally heat pressed to remove fuzz and fraying, and finally cut into an oval shape of an appropriate size. Examples of the shape are:
As shown in Figure 1, make two needle holes (2) and (3) near the center of the oval cut piece.
1), and when it is used, a suture thread (4) is passed through the needle holes (2) and (3) during surgery as shown in FIG.
また、本発明を構成する素材として具体例を挙げるなら
ば、生体親和性が大きく炎症反応も少ない、既に吸収性
縫合糸として実績のあるポリグリコール酸やポリグラフ
チン910などの適用が可能で、吸収性において同等程
度のものの組み合せが共用上望ましい、しかしながら、
非吸収性の縫合糸を用いる場合にもこれらのプレジェッ
トの適用は可能である。In addition, to give a specific example of the material constituting the present invention, it is possible to use polyglycolic acid and polygraftin 910, which have high biocompatibility and little inflammatory reaction, and which have already been used as absorbable suture threads. Combinations of similar genders are desirable for common use, however,
Application of these pledgets is also possible when using non-absorbable sutures.
更に、強力や加水分解速度のコントロールは用いる素材
、及びその組み合せにより可能であるが糸の段階での延
伸や熱処理条件あるいは不織布に ゛なったの
ちの熱プレス条件などによりコントロールすることがで
きる。Furthermore, the strength and hydrolysis rate can be controlled by the materials used and their combinations, but can also be controlled by stretching and heat treatment conditions at the yarn stage, or by hot pressing conditions after turning into a nonwoven fabric.
また、紡糸前にポリマーチップに人体に無害な色素を含
有させておき溶融紡糸により着色した繊維を得ることが
でき、白色もしくはそれに近い色の場合、手術時の出血
で赤く染まり判別しにくくなるが適当な色1例えば緑色
や紫色に着色したプレジェットの場合は手術時も判別が
容易で、手術を容易ならしめる利点を有する。In addition, it is possible to obtain colored fibers by melt spinning by adding a dye that is harmless to the human body to the polymer chip before spinning, and if the fiber is white or a color close to white, it will be dyed red due to bleeding during surgery, making it difficult to distinguish. Pledgets colored in an appropriate color 1, for example, green or purple, have the advantage of being easy to distinguish during surgery, making the surgery easier.
(作用)
本発明は、前記のように外科手術において縫合糸にかか
る張力が体組織の断裂をきたす可能性がある場合、即ち
、軟組織や薄い組織の縫合や広範な吻合の場合などに当
て布として用いると、糸のみにかかっていた張力がプレ
ジェットにより分散し5体組織を損傷する可能性を減す
ると共に、縫合の確実性を増すものである。(Function) As described above, the present invention is suitable for use in cases where the tension applied to suture threads in surgical operations may cause rupture of body tissue, that is, in cases of suturing soft or thin tissue or extensive anastomosis. When used as a thread, the tension applied only to the thread is dispersed by the pledget, reducing the possibility of damaging body tissues and increasing the reliability of suturing.
更に、加水分解性であるので、補強材としての機能を果
した抜栓々に体内に吸収され、異物として長く体内に留
ることがなく、その吸収速度は。Furthermore, since it is hydrolyzable, it is absorbed into the body through the plugs that function as reinforcing materials, so it does not remain in the body as a foreign substance for a long time, and its absorption rate is low.
前述したようにポリマー組成や製造条件により任意にコ
ントロールできる特徴を有する。As mentioned above, it has characteristics that can be controlled arbitrarily by changing the polymer composition and manufacturing conditions.
以下、その構成について例を挙げて説明する。The configuration will be explained below by giving an example.
(実施例)
[製造例]
フェノールlOに対し、トリクロロフェノール7の割合
で混合した溶媒中にて溶解し、これを190℃で3分間
加熱した後30℃まで冷却して測定したときの粘度(M
sp/c)が1.5であるポリグリコール酸チップを2
45℃で溶融紡糸し、延伸して12フイラメントで35
デニールの糸を得た。(Example) [Production Example] The viscosity when dissolved in a solvent containing 7 parts trichlorophenol to 10 phenol, heated at 190°C for 3 minutes, then cooled to 30°C, and measured. M
2 polyglycolic acid chips with sp/c) of 1.5
Melt-spun at 45°C and stretched to 35 mm with 12 filaments.
I got a denier thread.
これを106℃で3時間熱処理したのち筒編機によりチ
ューブ状のニットとした。This was heat-treated at 106° C. for 3 hours and then knitted into a tube shape using a tube knitting machine.
このニットを4重に重ねたものをニードルパンチして編
目がほとんどわからない程度の不織布とし、さらにこの
不織布を100℃で5分間熱プレスして毛羽立ちやほつ
れを防止し、均斉且つ伸びを有する素材を構成した。This 4-ply knit is needle-punched to create a non-woven fabric with almost no visible stitches, and this non-woven fabric is then heat-pressed at 100°C for 5 minutes to prevent fuzzing and fraying, creating a material with uniformity and stretch. Configured.
これを3 m m X 8 m m大の小判状にカット
し、中央寄りに2つの穴をうがってプレジェットとした
。This was cut into an oval shape of 3 mm x 8 mm, and two holes were punched near the center to make a pledget.
[物性評価] 前記のようにして得たプレジェットを1n−vitr。[Evaluation of the physical properties] 1n-vitr of the pledget obtained as described above.
での加水分解性評価に供した。It was used for hydrolyzability evaluation.
これは第3図に示すようにプレジェットの針穴(3)に
輪状に1帰結合糸(5)を挿通し、これに荷重(6)を
かけていったときの抗張力を計測したものである。As shown in Figure 3, the tensile strength was measured when a single-return yarn (5) was inserted in a loop through the needle hole (3) of the pledget and a load (6) was applied to it. be.
37°Cの生理食塩水中にそれぞれ3日、5日、7日、
14日間と浸漬し、初期の抗張力と比較した結果を第1
表に示す。in saline at 37°C for 3, 5, and 7 days, respectively.
The results were compared with the initial tensile strength after 14 days of immersion.
Shown in the table.
第1表
この結果によると、5日日まではほとんど初期と変らぬ
抗張力を有しており70目あたりから徐々に分解が始ま
り14日1でかなり弱くなっていることかわかるが目的
とする実用上十分な機能である。Table 1: According to the results, the tensile strength is almost the same as the initial strength up to the 5th day, and it gradually begins to decompose around the 70th day, becoming considerably weaker at the 14th day. It is fully functional.
[実用評価]
前記により構成したプレジェットを体重7〜15Kgの
雑種成犬の頚部気管を第7.8気管軟骨間で横断し、中
枢末梢両側に第4図に示すような方法、即ち、針(7)
付き縫合糸(4)として4−0号のVicryl糸(商
品名)を用いて膜様部は全層縫合になるように1ケ所、
気管軟骨部は5ケ所端々吻合し、第6図のように接合し
てその経過を観察した。[Practical Evaluation] The pledget constructed as described above was passed through the cervical trachea of an adult mongrel dog weighing 7 to 15 kg between the 7th and 8th tracheal cartilage, and the method shown in Fig. 4 was applied to both central and peripheral sides, that is, a needle was inserted. (7)
Using No. 4-0 Vicryl thread (trade name) as the attached suture (4), the membranous part was sutured in one place so that the entire thickness was sutured.
The tracheal cartilage was anastomosed end-to-end at five locations and joined as shown in Figure 6, and its progress was observed.
尚、図中(8)(9)は気管である。Note that (8) and (9) in the figure are the trachea.
これの吻合部状態をみるため術後1週、2週。1 and 2 weeks after the operation to check the condition of the anastomosis.
4週、2号月、3ケ月、10ケ月目に実験犬を層殺し、
材料の分解吸収速度2組織反応、吻合部における縫合糸
のゆるみ、プレジェットの脱落の程度を観察した。尚、
対照には重版のテフロンプレジェットを用いた。Experimental dogs were killed at 4 weeks, 2 months, 3 months, and 10 months.
Degradation and absorption rate of the material 2. Tissue reaction, loosening of the suture at the anastomotic site, and extent of pledget falling out were observed. still,
A reprinted Teflon pledget was used as a control.
その結果、材料の初期引張強度は4.0kgfとテフロ
ンプレジェットの0.4kgfに比ヘテ大きく、加水分
解下で1週間目まで強度を保持した。2i!!間口以降
は急速に分解が進んだ。As a result, the initial tensile strength of the material was 4.0 kgf, which is significantly higher than the Teflon pledget's 0.4 kgf, and the strength was maintained for up to one week under hydrolysis. 2i! ! Decomposition progressed rapidly after the frontage.
気管吻合実験では、1例対照に用いたテフロンプレジェ
ットが術後110目に気管内に脱落、周囲に生じた肉芽
により窒息死亡した。これを組織学的に検討すると、周
囲に強い組織反応が生じ。In the tracheal anastomosis experiment, in one case, the Teflon pledget used as a control fell off into the trachea 110 days after the operation, and the patient died of suffocation due to the granulation that had formed around it. When this was examined histologically, a strong tissue reaction occurred in the surrounding area.
気管軟骨一部溶解してテフロンプレジェットは結合織で
encapselされ搬痕状になることがわかった。ポ
リグリコール酸プレジェット例では吻合部の狭窄、プレ
ジェットの脱落、糸のゆるみによる吻合不全をきたした
ものはなかった0組織学的にはポリグリコール酸プレジ
ェットでは術後iiI!!間より材料繊維間に細胞が入
り込み材料が軟化膨大し、吸収されてゆく、尚、分解過
程における周囲への組織反応は少なく、3号月後には分
解吸収されていた。It was found that the tracheal cartilage was partially dissolved and the Teflon pledget was encapsulated with connective tissue, resulting in a scar-like appearance. None of the polyglycolic acid pledget cases suffered from anastomotic failure due to anastomotic stenosis, pledget dislodgement, or thread loosening. Histologically, the polyglycolic acid pledget showed postoperative iii! ! Cells entered between the fibers of the material, causing the material to soften, expand, and be absorbed.However, there was little tissue reaction to the surrounding tissue during the decomposition process, and the material was decomposed and absorbed after three months.
(発明の効果)
本発明は、以上のように従来にない優れた特徴を有し、
外科手術における縫合部補強用として極めて好適に適用
可能なものである。(Effects of the Invention) As described above, the present invention has unprecedented features,
It is extremely suitable for use in reinforcing sutures in surgical operations.
特に、その素材としてはポリグリコール酸、及び、これ
と乳酸との共重合体を用いるものであり、その重合度、
重合比率の調製により分解性のコントロールが可能なも
のである。In particular, the material used is polyglycolic acid and a copolymer of this and lactic acid, and the degree of polymerization,
Degradability can be controlled by adjusting the polymerization ratio.
また、その製法においては、特に不織布・として適用す
るのが好適であるが、ランダムウェブによる不織布化は
その密度の均一化において均等でなく、この点、実施例
で挙げたように、特に編、織成した生地を複数枚重ね、
これをニードルパンチングして不織布化するのが均一な
密度で、しかも編地においては適度な伸縮性を有するた
めこれの適用組織になじみやすく好適である。In addition, in the manufacturing method, it is especially suitable to apply it as a non-woven fabric, but the non-woven fabric using a random web is not uniform in its density, and in this point, as mentioned in the examples, especially knitting, Layering multiple layers of woven fabric,
It is preferable to needle-punch this material to make it into a non-woven fabric, which has a uniform density, and also has appropriate elasticity in knitted fabrics, making it easy to adapt to the tissue to which it is applied.
第1図は本発明のプレジェットを例示した斜視図。第2
図は、その使用状態を例示した斜視図。
第3図は抗張力評価を示した正面図、第5図は実施例に
おける気管の吻合状態を示した正面図、第6図は第5図
において気管を吻合した状態を示した正面図。
(1)−一−プレジェット (2)(3)−m−針穴
(4)−−一縫合糸
(8)(9) −−一気管FIG. 1 is a perspective view illustrating a pledget of the present invention. Second
The figure is a perspective view illustrating the state of use. FIG. 3 is a front view showing tensile strength evaluation, FIG. 5 is a front view showing the state of anastomosis of the trachea in the example, and FIG. 6 is a front view showing the state of anastomosis of the trachea in FIG. (1) - one - pledget (2) (3) - m - needle hole (4) - one suture (8) (9) - one trachea
Claims (1)
療用プレジェット。 2、生体内分解吸収性の熱可塑性高分子がポリグリコー
ル酸であることを特徴とする特許請求の範囲第1項記載
の医療用プレジェット。 3、生体内分解吸収性の熱可塑性高分子がグリコール酸
と乳酸の共重合体であることを特徴とする特許請求の範
囲第1項記載の医療用プレジェット。[Claims] 1. A medical pledget made from a biodegradable and absorbable thermoplastic polymer. 2. The medical pledget according to claim 1, wherein the biodegradable and absorbable thermoplastic polymer is polyglycolic acid. 3. The medical pledget according to claim 1, wherein the biodegradable and absorbable thermoplastic polymer is a copolymer of glycolic acid and lactic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61240922A JPS6395041A (en) | 1986-10-09 | 1986-10-09 | Medical pledget |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61240922A JPS6395041A (en) | 1986-10-09 | 1986-10-09 | Medical pledget |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6395041A true JPS6395041A (en) | 1988-04-26 |
JPH0518579B2 JPH0518579B2 (en) | 1993-03-12 |
Family
ID=17066644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61240922A Granted JPS6395041A (en) | 1986-10-09 | 1986-10-09 | Medical pledget |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6395041A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0597427A1 (en) | 1992-11-11 | 1994-05-18 | MITSUI TOATSU CHEMICALS, Inc. | Degradable non-woven fabric and preparation process thereof |
US6355772B1 (en) | 1992-10-02 | 2002-03-12 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
US8043629B2 (en) * | 2002-11-14 | 2011-10-25 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Bioabsorbable synthetic nonwoven fabric holding thrombin |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1290375B1 (en) * | 1994-06-03 | 1998-12-03 | Gunze Kk | ELEMENT MADE OF BIODEGRADABLE AND BIABORBSIBLE MATERIAL USABLE IN THE SURGICAL FIELD FOR REINFORCEMENT OF FABRIC AREAS TO BE SEWED. |
JP2008279011A (en) * | 2007-05-09 | 2008-11-20 | Gunze Ltd | Medical prosthetic material |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5798556A (en) * | 1980-10-20 | 1982-06-18 | American Cyanamid Co | Refomation of polyglycolic acid obtaining variable vital body physical properties |
-
1986
- 1986-10-09 JP JP61240922A patent/JPS6395041A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5798556A (en) * | 1980-10-20 | 1982-06-18 | American Cyanamid Co | Refomation of polyglycolic acid obtaining variable vital body physical properties |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355772B1 (en) | 1992-10-02 | 2002-03-12 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
EP0597427A1 (en) | 1992-11-11 | 1994-05-18 | MITSUI TOATSU CHEMICALS, Inc. | Degradable non-woven fabric and preparation process thereof |
US5437918A (en) * | 1992-11-11 | 1995-08-01 | Mitsui Toatsu Chemicals, Inc. | Degradable non-woven fabric and preparation process thereof |
US8043629B2 (en) * | 2002-11-14 | 2011-10-25 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Bioabsorbable synthetic nonwoven fabric holding thrombin |
Also Published As
Publication number | Publication date |
---|---|
JPH0518579B2 (en) | 1993-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8481074B2 (en) | Hemostatic microfibrous constructs | |
US5393594A (en) | Absorbable non-woven fabric | |
KR20050084325A (en) | Medical film | |
DE602004004729T2 (en) | High-strength seam with absorbable core | |
BR112012029190B1 (en) | CLOTH IN MULTIPLE LAYERS ABSORBIBLE AND REINFORCED FOR HEMOSTATIC APPLICATIONS | |
DE2515970A1 (en) | COMPACT FELT | |
JP2001161725A (en) | Flat plane graft, method of manufacturing the same, and use in surgery | |
KR20130060276A (en) | A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture | |
DE2206144A1 (en) | COPOLYMERS ABSORBABLE BY LIVING MAMMALIAN TISSUES | |
US11555262B2 (en) | Two-sides gripping knit | |
EP1778479A2 (en) | Hemostatix microfibrous constructs | |
JP4554916B2 (en) | Medical film | |
JPS6395041A (en) | Medical pledget | |
JP2009533568A (en) | Absorbent reinforced multilayer fabric for use in medical devices and method of manufacture | |
JP2962606B2 (en) | Medical prostheses | |
JP5616196B2 (en) | Medical prosthesis | |
EP2011523A1 (en) | Blood-stopping non-woven fabric | |
JPH01131668A (en) | Readsorptive net for surgery | |
RU2581356C2 (en) | Absorbable haemostatic agent for laparoscopic management | |
JPH0431071Y2 (en) | ||
NO833768L (en) | ABSORBABLE HEMOSTATIC MATERIAL. | |
DE2348685C2 (en) | Process for the production of a non-woven fabric based on collagen | |
JP2019141500A (en) | Tissue reinforcing material for automatic suturing device | |
CN118304479A (en) | Absorbable tissue reinforcing material and preparation method thereof | |
JPS5991962A (en) | Absorbable hemostatic material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |